Home > Boards > US OTC > Medical - Healthcare >

Decision Diagnostics Corp. (DECN)

DECN RSS Feed
Add DECN Price Alert      Hide Sticky   Hide Intro
Moderator: lucky,mydog, UP Trend, pumper_stumper
Search This Board: 
Last Post: 9/26/2020 11:39:50 AM - Followers: 448 - Board type: Free - Posts Today: 6

 

     $DECN       
https://www.otcmarkets.com/stock/DECN/profile

                                                          

On April 23, 2020, the SEC announced an action against DECN, suspending trading in the company's stock for two weeks.  There is currently a SEC court case ongoing where the SEC has identified the many reasons for the suspension.

https://www.otcmarkets.com/stock/DECN/news/SEC-Suspension-of-Trading?id=260085

                                     
Decision Diagnostics Corp. is a nationwide prescription and non-prescription diagnostics and home testing products distributor. We market our GenUltimate, GenSure, PetSure (test strips for dogs and cats) and GenChoice (in FDA 510(k) review), our panacea GenUltimate TBG glucose test strips and meter (in 3rd party testing), our GenPrecis test strips and meter (for private label sale), and our GenUltimate 4Pets glucose test strips and meter for the diabetic testing of dogs, cats and horses. We are also FDA approved and have complete R&D and manufacturing facilities in South Korea. We made the the first alternative glucose testing strips sold to the market in this decade and the first alternative test strip products sold into the market since early 2008.

                                                                                             
                                                                        



                                      

                                                                                                
               

Keith Berman, CEO of DECN commented, "GenViro for the Coronavirus (covid19) began as an outgrowth of our GenUltimate TBG product line. What makes the testing for the Coronavirus possible, and the GenUltimate TBG special, is the company's Impedance measurement technology.

https://www.frontiersin.org/articles/10.3389/fmicb.2015.00940/full

While infectious disease testing and management has not previously been a part of our business model, we seized on this "do good" opportunity because our "Gen" line of products are and have been manufactured since 2016 in what is ground zero for Coronavirus (covid19) in Daegu, Korea. The company will have available samples of the blood of those previously infected available for testing as the company quickly converts its GenUltimate TBG methods and Precise meter, into a precise infectious disease testing device for the screening for Coronavirus."

                                                    



Read Recent Press Releases » 

Review Recent Financial Reports »

Visit PharmaTech Solutions, Inc. »

                                 

MOST RECENT PRESS RELEASE - https://www.accesswire.com/578719/DECN-Jumps-into-Screening-and-Testing-Channel-For-Coronavirus-COVID19-Using-Its-Innovative-Impedance-Technology-First-Implemented-In-Its-GenUltimate-TBG

Today, in a break-through discussed for the first time, DECN announces in this first of three releases, expected in the next 10 days, the introduction of our new screening methodology for the Coronavirus (Covid19). Our product is timely, simple to use, cost effective and will be commercial ready in the summer of 2020.

Keith Berman, CEO of DECN commented, "We have the technology perfected which will take months off of the development schedule. Our impedance powered diagnostic will be field tested at ground-zero in Daegu, Korea, where 700+ people have already been overcome by Coronavirus (COVID19) and where all of the clinical studies for our "Gen" products were tested. Our timing here is spot-on."
 


Mod Cash4 Updated Ibox 3/11/2020

NEWS
https://www.otcmarkets.com/stock/DECN/news



$DECN Provides First Looks At Its GenViro(TM) Corona Virus Screening Kit & First Year Product Forecast of 420 Million Kits, with Sales Beginning Late 3Q 2020

Press Release | 03/11/2020

Initial Sales of GenVirotm Covid19 to be to Big Box Pharmacies, Group Practices, Long Term Care Facilities and Stand-alone Clinics; Average Wholesale Price of the Kit Expected to be @ $6.95

LOS ANGELES, CA / ACCESSWIRE / March 11, 2020 / Decision Diagnostics Corp. (OTC PINK:DECN) is an 18-year old, diabetes-focused bio-technology development firm, manufacturer, quality plan administrator, FDA registered medical device customer support organization, and exclusive worldwide sales and regulatory process agent for the GenUltimate! ("Sunshine") diabetes test strip, its GenAccord! systems for the uninsured and under-insured, its GenChoice! ("Ladybug") test strip now in the later stages of FDA 510(k) prosecution, and its GenUltimate Precis products manufactured for International markets.

Today, in the third discussion of our break-through test for the coronavirus (COVID19), we present the Coronavirus test kit and the Phase 1 unit forecast. The introduction of our new screening methodology for the Coronavirus (Covid19) will provide a timely, simple to use and cost effective solution for the screening of the frightening COVID19 virus. First uses of our kits will be in pharmacies, doctor's offices, clinics and urgent care centers, and long term care facilities. We anticipate the sale of 420,000,000 kits in the first full year of commercial sale. The company has retained FDA counsel who is in the process of securing expected emergency waiver for diagnostics and diagnostic devices.

Keith Berman, CEO of DECN commented, "Because we perfected the Impedance technology in 2019 for our GenUltimate TBG glucose test strip and meter, we have shaved months off of the development time for the GenViro! device. Our GenViro! impedance powered diagnostic will be field tested at ground-zero in Daegu, Korea, the location of our factory and the hospital based testing site, and where 1200+ people have already been overcome by Coronavirus (COVID19). Everyone who has succumbed to this type of flu, has been a blood donor at their testing facility or hospital. Daugu, Korea is one of the few places where acquiring donors will not be an issue. GenViro! will be a perfect storm product and our timing here is spot-on. Our biggest challenge will be meeting the expected crushing demand. For that we prepared, and are interviewing most likely partners currently."

Mr. Berman continued, "I cannot say often enough, we are developing a Coronavirus screening method, not a cure or a vaccine for the Covid19 virus. That being said, our screening method should allow for 80% of those who suspect that they carry the Coronavirus, to exit the potential quarantine in those places where Coronavirus is rampant, and a higher percentage where it is not.

GenViro! 12-Month Forecast

Number of Months

1

2

3

4

5

6

7

8

9

10

11

12

SUM

Year 1

Apr-20

May-20

Jun-20

Jul-20

Aug-20

Sep-20

Oct-20

Nov-20

Dec-20

Jan-21

Feb-21

Mar-21

 
                           

New Facility Customers

0

0

0

0

0

5000

5000

5000

5000

5000

5000

5000

 

Retained Facilities

0

0

0

0

0

0

5000

10000

15000

20000

25000

30000

 

Total Facility Customers

0

0

0

0

0

5000

10000

15000

20000

25000

30000

35000

35,000

Kits Consumed

0

0

0

0

0

15,000,000

30,000,000

45,000,000

60,000,000

75,000,000

90,000,000

105,000,000

420,000,000

We are not resting our laurels with our GenViro development. Later product entries will be test methods for Polio, Ebola (Marburg), Bird Flu, and SARS. The cost of our test kits will be sold in a price range of $4.95 to $7.95 per use. The Coronavirus kit will be sold for $6.95. Each kit sold will carry enough diagnostic for two tests, a primary test, and a test in reserve in case of human error in administrating the primary test. We plan to provide our diagnostics initially for use at hospitals, doctors' offices, and clinics. Once production ramps up, we will offer testing kits and meters to patients for testing at-home.

Mr. Berman concluded, "As you might imagine with a product announcement of such importance, we have been contacted by a number of potential partners for our kit, as well as companies who were not chosen last time to proceed past the proposition stage. The company's first choice for partnering will be a company that made "the cut" last time for our GenUltimate! TBG product. We will discuss partnering potential in a coming release. For the moment, the company is content calling on big box and long term care chains through its existing distributors and agents."

DECN also markets its PetSure! test strip for the diabetic testing of dogs and cats, a diagnostic specifically designed to run on the market leding Zoetis Alpha Trak meter system as well as the GenUltimate! 4Pets Test strip and Avantage! meter. The company has also just introduced its GenExpidient! Universal Translator for bio-sensor devices of different manufacture. A GenExpidient! device will be included in every Covid19 kit. Having such a device will lower the incidence of cleaning and disinfecting the GenViro! meter.

ABOUT DECISION DIAGNOSTICS CORP

Decision Diagnostics Corp. is the leading manufacturer and worldwide distributor of diabetic test strips engineered to operate on legacy glucose meters. DECN's products are designed to operate efficiently and less expensively on certain glucose meters already in use by almost 7.5 million diabetics worldwide. With new inspired technology diabetic test strips already in the final stages of development, DECN products compete on a worldwide scale with legacy manufacturers currently selling to 71+ percent of a $15+ billion at-home testing market. The company's GenUltimate TBG product is not yet available for sale in the United States or Puerto Rico but is for sale in select International markets since late February 2020.

Forward-Looking Statements:

This release contains the company's forward-looking statements which are based on management's current expectations and assumptions as of March 11 2020, regarding the company's business and performance, its prospects, current factors, the economy, and other future conditions and forecasts of future events, circumstances, and results.

CONTACT INFORMATION:

Decision Diagnostics Corp.
Keith Berman (805) 446-2973

info@decisiondiagnostics.co
www.genultimate.com
www.genultimatetbg.com
www.petsureteststrips.com
www.pharmatechdirect.com

SOURCE: Decision Diagnostics Corp.



View source version on accesswire.com:
https://www.accesswire.com/579985/DECN-Provides-First-Looks-At-Its-GenViroTM-Corona-Virus-Screening-Kit-First-Year-Product-Forecast-of-420-Million-Kits-with-Sales-Beginning-Late-3Q-2020
 
DECN SECURITY DETAILS

Share Structure

 
Authorized Shares
494,995,000
 
Outstanding Shares
 
09/11/20 -  313,434,787
08/07/20 - 305,063,608
07/10/20 - 302,663,608
05/15/20 - 267,213,123
04/03/20 - 212,000,000
03/31/20 - 199,792,833
03/06/20 - 159,999,161
12/31/19 - 156,679,161
12/31/18 - 134,551,840
12/31/17 - 110,241,640
12/31/16 - 84,639,908 

 
07/10/2020
Restricted
5,969,436
 
Unrestricted
296,694,172
 

 

 
 
 
DECN
Current Price
Volume:
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
DECN News: The Rapid Rise of Alternet Systems, Inc. (OTCMKTS: ALYI) 07/06/2020 09:16:48 AM
PostSubject
#91633  Sticky Note DECN FAQ - "Call the company and ask." pumper_stumper 09/21/20 03:58:57 PM
#85548  Sticky Note Instead, here we are a week after the IPwatcher 06/10/20 01:06:00 PM
#79160  Sticky Note DECN $$ https://newyork.cbslocal.com/2020/05/05/coronavirus-covid-19-decision-d mr pancake 05/05/20 06:43:46 PM
#91784   "Still a scam???" loanranger 09/26/20 11:08:39 AM
#91783   "If DECN didn't make the list, why is loanranger 09/26/20 11:07:34 AM
#91782   https://www.investorsobserver.com/news/stock-update/is-decision-diagnostics-corp marekt 09/26/20 11:01:46 AM
#91781   Another day and still NO E.U.A.Tick-Tock-Tick-Tock-Tick-Tocl-Tick-Tock Tick-Tock mugsy4900 09/26/20 08:38:32 AM
#91780   Officially a Semi finalist sroks5 09/26/20 12:16:39 AM
#91779   Johnny If DECN didn't make the list, why is I ll be back 09/25/20 11:41:29 PM
#91778   Hey Berman, remember this one? plutoniumimplosion 09/25/20 09:07:26 PM
#91777   Hey Berman, remember this one? pumper_stumper 09/25/20 02:33:36 PM
#91776   So then it would not be correct to pumper_stumper 09/25/20 02:31:01 PM
#91775   It's the only DECN looks you get from Jelly Bean 09/25/20 02:27:00 PM
#91774   Lmfao. No $mil for Bozo. No Nobel Johnny_C 09/25/20 01:27:08 PM
#91773   "Product launches tomorrow. " pumper_stumper 09/25/20 01:24:19 PM
#91772   It's not a good look. IPwatcher 09/25/20 12:30:01 PM
#91770   Nuns are a good time! timetravelerdos 09/25/20 12:05:07 PM
#91769   It's not a good look. plutoniumimplosion 09/25/20 11:54:32 AM
#91768   "Not lying at all." loanranger 09/25/20 10:51:02 AM
#91767   Next week the first 200 samples sent, you Johnny_C 09/25/20 10:31:55 AM
#91766   Lol. Not lying at all. There will Johnny_C 09/25/20 10:30:19 AM
#91765   Seems like with all the DECN Fairy tales timetravelerdos 09/25/20 10:29:13 AM
#91764   "You sure about that, 76 percent of entries eliminated." loanranger 09/25/20 09:06:06 AM
#91763   That's like waving garlic in front of a vampire! pumper_stumper 09/25/20 08:31:03 AM
#91762   Dude, the Companies that have made the list Johnny_C 09/25/20 07:47:02 AM
#91761   You are wrong about no list. Sorry Charlie Johnny_C 09/25/20 07:42:25 AM
#91760   You sure about that, 76 percent of entries Johnny_C 09/25/20 07:41:41 AM
#91758   Absolutely ! Add me to the list timetravelerdos 09/25/20 12:25:12 AM
#91757   "TAUG's paid consultant hasn't seen a list either." loanranger 09/24/20 10:08:01 PM
#91756   However, if we are to believe that you plutoniumimplosion 09/24/20 09:00:51 PM
#91755   Add me to the patient ones waiting! pumper_stumper 09/24/20 07:40:36 PM
#91754   I wholeheartedly agree with those sentiments and your loanranger 09/24/20 07:29:54 PM
#91753   Dude, you are not on the list. Bozo plutoniumimplosion 09/24/20 07:19:56 PM
#91752   Who held? Like you said Real Covid stocks timetravelerdos 09/24/20 06:58:07 PM
#91751   Dude, you are not on the list. Bozo Johnny_C 09/24/20 06:47:48 PM
#91750   up from a 0.03 on March 1. gman3 09/24/20 04:53:04 PM
#91749   SOMETHINGS DEFINETLY COOKIN $$$$$$$$$$$.JMO. ajetforallofus 09/24/20 04:23:56 PM
#91748   Daily charts looking very good here ! GLA Hawkeye_tt 09/24/20 04:19:35 PM
#91746   Yikes!!! Another GREEN day! Up 18.42% timetravelerdos 09/24/20 04:07:23 PM
#91745   Well the finalist (top 20) list comes out pumper_stumper 09/24/20 03:20:44 PM
#91744   Contrary to what Bozo Berman's mouthpiece stated, Decn IPwatcher 09/24/20 03:04:07 PM
#91743   They told me DECN Could very well be pumper_stumper 09/24/20 02:42:17 PM
#91742   can someone answer this? timetravelerdos 09/24/20 02:35:33 PM
#91741   Outstanding Video and obviously has been a very timetravelerdos 09/24/20 02:27:05 PM
#91740   Contrary to what Bozo Berman's mouthpiece stated, Decn plutoniumimplosion 09/24/20 02:15:38 PM
#91739   I AGREE_ I REMEMBER WHEN I FIRST ALERTED BLULLISH 09/24/20 01:53:11 PM
#91737   Great video,should be on all the channels soon, RHF469usa 09/24/20 01:04:16 PM
#91736   Will be great to see the list of pumper_stumper 09/24/20 12:24:39 PM
#91735   Contrary to what Bozo Berman's mouthpiece stated, Decn Johnny_C 09/24/20 12:14:09 PM
#91734   Five months later, no answers to the very pumper_stumper 09/24/20 11:47:54 AM
#91733   Genviro video is out on youtube. https://www.youtube.com/watch?v=TgFD4PKqjdQ&fea sage4 09/24/20 10:49:24 AM
#91732   $decn $0.3 ^ 0.034 (12.78%) Taurus69 09/24/20 10:49:05 AM
#91731   Sold some at .34 before small pull back. jimbob4 09/24/20 10:38:11 AM
PostSubject
Consent Preferences